Amanta Healthcare Production Started
Amanta Healthcare successfully commissioned a 10.8 MWp solar plant for captive consumption. The facility became operational on May 30, 2026, aimed at reducing long-term operational costs.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
40 announcements with these filters
Amanta Healthcare successfully commissioned a 10.8 MWp solar plant for captive consumption. The facility became operational on May 30, 2026, aimed at reducing long-term operational costs.
Amanta Healthcare Limited submitted its Annual Secretarial Compliance Report for FY2026. The report by M/s. Kashyap R. Mehta and Partners confirms overall regulatory compliance with SEBI norms.
Amanta Healthcare Limited confirmed zero deviation in utilizing ₹126 Crore raised via its IPO. Funds were deployed towards capital expenditure and general corporate purposes.
Amanta reported FY26 revenue of ₹288cr with 22% EBITDA margins. Strategy focuses on high-margin SteriPort capacity expansion and renewable energy cost savings.
Amanta Healthcare approved a remuneration hike for MD Shri Bhavesh Patel to ₹13.29 Lakh monthly. The revision, effective April 2026, awaits shareholder approval via special resolution.
Amanta Healthcare appointed M/s. Kashyap R. Mehta & Partners as Secretarial Auditor for five years. Internal and Cost Auditors were also re-appointed for FY 2026-27.
Amanta Healthcare reported FY26 revenue of ₹287.68 Crore and 42% YoY profit growth. The company is currently executing major capacity expansions to drive sustainable future growth.
Amanta Healthcare reported FY26 revenue of ₹288 Cr (+5% YoY) and PAT of ₹15 Cr (+42% YoY), driven by improved margins and reduced finance costs.
Amanta Healthcare Ltd reported revenue from operations of ₹77 Cr (+6.8% YoY) and net profit of ₹5.5 Cr (-8.3% YoY) for Q4 FY26.
Amanta Healthcare reported a total income of ₹291.05 Crore for FY26. The Board also updated policies for insider trading and whistleblowers.